等待开盘 06-25 09:30:00 美东时间
+0.010
+2.62%
Soligenix ( ($SNGX) ) just unveiled an update. On June 10, 2026, Soligenix rece...
06-13 05:05
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, noted
06-08 19:34
Thermostability, immunogenicity and efficacy data against related viruses provides firm starting point for rapid vaccine development PRINCETON, N.J., June 8, 2026 /PRNewswire/ -- Soligenix, ...
06-08 19:30
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
06-06 02:24
Soligenix ( ($SNGX) ) has issued an announcement. On May 28, 2026, Soligenix, I...
05-29 07:15
Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares rose 7% in pre-market trading as Q2 guidance exceeded expectations.
05-27 17:10
Soligenix says ThermoVax platform supports rapid development of thermostable Bundibugyo virus vaccine Soligenix flagged its ThermoVax platform as a rapid starting point for a new Bundibugyo virus vaccine in response to the Congo outbreak. Preclinical work was already presented as supportive evidence
05-26 19:32
https://www.cdc.gov/ebola/situation-summary/index.html
05-18 23:25
Soligenix press release (SNGX): Q1 GAAP EPS of $0.28. Research and development expenses were $1.8 million as compared to $1.9 million for the quarter ended March 31, 2026 and 2025, respectively. The d...
05-08 19:44